Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia
Karina Althaus(Institute for Transfusion Medicine), Tamam Bakchoul(Institute for Transfusion Medicine), Ulrich J. Sachs(Institute of Immunology), Dominik F. Vollherbst(Heidelberg University), Gabor C. Petzold(University Hospital Bonn), Hansjörg Bäzner(Klinikum Stuttgart), Nicole Schneiderhan‐Marra(Natural and Medical Sciences Institute), Martin Bettag(Krankenhaus der Barmherzigen Brüder Trier), Falko Fend(University of Tübingen), Nils Heyne(University of Tübingen), Janis A. Müller(Philipps University of Marburg), Martina Guthoff(University of Tübingen), A. Beck(University Hospital Ulm), Matthias Maschke(Krankenhaus der Barmherzigen Brüder Trier), Jens Müller(Universität Ulm), Verena Warm(University of Tübingen), Marc E. Wolf(Heidelberg University), Lisann Pelzl(University of Tübingen), Andreas Viardot(University Hospital Ulm), Caroline Limpach(Krankenhaus der Barmherzigen Brüder Trier), Jan Münch(Universität Ulm), Anurag Singh(Institute for Transfusion Medicine), Hassan Jumaa(University of Freiburg), Kornelia Kreiser(University Hospital Ulm), Simon Nagel(Heidelberg University), Christoph Schlegel(University Hospital Ulm), Jochen Steiner(University of Tübingen), Hans Henkes(Klinikum Stuttgart), Hans Bösmüller(University of Tübingen), Peter Mӧller(University Hospital Ulm), Bernd Pötzsch(Institute for Transfusion Medicine), Franziska Dorn(University Hospital Bonn), Winfried A. Willinek(Krankenhaus der Barmherzigen Brüder Trier), Günalp Uzun(Institute for Transfusion Medicine)
Cited by 136
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
|The Lancet Oncology|2015|613
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523